ZBTB20 and hepatocellular carcinoma: Similarly, ZBTB20 has been found to be an important poor prognostic factor in hepatocellular carcinoma owing to its elevated levels in HCC and importantly, metastatic recurrence rates were found to be higher in HCC patients with high ZBTB20 levels (Wang et al., 2011).